Sankar Ghosh Selected Research

Sankar Ghosh Research Topics

Disease

27	Inflammation (Inflammations) 01/2020 - 06/2003
11	Neoplasms (Cancer) 11/2023 - 07/2004
6	Infections 11/2017 - 03/2004
5	Necrosis 04/2011 - 06/2006
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 06/2002
3	Sepsis (Septicemia) 10/2018 - 08/2015
3	Experimental Arthritis 08/2010 - 06/2004
2	Hypoxia (Hypoxemia) 01/2021 - 01/2021
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 07/2004
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2019 - 03/2015
2	Neuroinflammatory Diseases 09/2012 - 07/2004
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2009 - 05/2007
2	Arthritis (Polyarthritis) 01/2006 - 12/2005
2	Rheumatoid Arthritis 01/2006 - 12/2005
1	Carcinogenesis 11/2023
1	Diabetes Mellitus 01/2021
1	Metaplasia 01/2020
1	Adenocarcinoma 01/2020
1	Pancreatitis 01/2020
1	Dermatitis 10/2019
1	Lung Injury 01/2019
1	Nephritis 01/2018
1	Melanoma (Melanoma, Malignant) 09/2017
1	Celiac Disease (Celiac Sprue) 04/2016
1	Hypersensitivity (Allergy) 01/2016
1	Asthma (Bronchial Asthma) 01/2016
1	Mouth Neoplasms (Oral Cancer) 08/2015
1	Skin Diseases (Skin Disease) 03/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 03/2015
1	Mucositis 02/2014
1	Cysts 01/2013
1	Toxoplasmosis 01/2013
1	Salmonella Infections (Salmonellosis) 12/2012
1	Obesity 01/2011
1	Type 2 Diabetes Mellitus (MODY) 01/2011
1	Atherosclerosis 01/2011
1	Overnutrition 01/2011
1	Septic Shock (Toxic Shock Syndrome) 08/2010
1	Dry Eye Syndromes (Dry Eye Syndrome) 08/2010
1	Keratoconjunctivitis Sicca 08/2010
1	Keratitis 08/2010
1	Sjogren's Syndrome (Sjogren Syndrome) 08/2010

Drug/Important Bio-Agent (IBA)

14	NF-kappa B (NF-kB)IBA 08/2010 - 06/2003
11	Transcription Factors (Transcription Factor)IBA 11/2023 - 06/2003
7	CytokinesIBA 10/2018 - 11/2007
7	Peptides (Polypeptides)IBA 09/2012 - 06/2004
5	LipopolysaccharidesIBA 01/2021 - 06/2006
5	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019 - 03/2002
4	ras ProteinsIBA 11/2023 - 09/2014
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2010 - 06/2004
3	Therapeutic UsesIBA 01/2021 - 07/2004
3	Long Noncoding RNAIBA 01/2020 - 04/2016
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2011
3	Interleukin-12 (IL 12)IBA 01/2013 - 06/2005
3	I-kappa B KinaseIBA 11/2007 - 07/2004
2	Monomeric GTP-Binding ProteinsIBA 11/2023 - 08/2015
2	Messenger RNA (mRNA)IBA 01/2020 - 10/2009
2	RNA (Ribonucleic Acid)IBA 11/2017 - 01/2013
2	AntigensIBA 01/2016 - 12/2012
2	Profilins (Profilin)IBA 01/2013 - 01/2013
2	Phosphotransferases (Kinase)IBA 09/2012 - 12/2005
2	Protein Kinases (Protein Kinase)IBA 11/2010 - 02/2008
2	GangliosidesIBA 10/2009 - 05/2007
2	(N- acetylneuraminyl)- galactosylglucosylceramide N-acetylgalactosaminyltransferaseIBA 10/2009 - 05/2007
2	MAP kinase kinase kinase 7IBA 02/2008 - 11/2005
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Orphan Nuclear ReceptorsIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	InterleukinsIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	CalciumIBA 01/2020
1	GTP Phosphohydrolases (GTPases)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 10/2019
1	p38 Mitogen-Activated Protein KinasesIBA 10/2019
1	AnisomycinIBA 10/2019
1	Interleukin-17 (Interleukin 17)IBA 10/2019
1	Imiquimod (Aldara)FDA LinkGeneric 10/2019
1	doramapimodIBA 10/2019
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019
1	Methylprednisolone FDA LinkGeneric 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Deubiquitinating EnzymesIBA 12/2016
1	Immune Checkpoint InhibitorsIBA 12/2016
1	InflammasomesIBA 03/2016
1	loricrinIBA 11/2015
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	Nucleic AcidsIBA 01/2013
1	nasIBA 01/2013
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 04/2011
1	LipidsIBA 01/2011
1	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2010
1	I kappa B beta proteinIBA 08/2010
1	Type I Tumor Necrosis Factor ReceptorsIBA 08/2010
1	Interferon Type IIBA 04/2009

Therapy/Procedure

7	Therapeutics 01/2020 - 11/2011
2	Immunotherapy 01/2020 - 09/2017
1	Drug Therapy (Chemotherapy) 11/2011